Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Immunome Inc (IMNM)
Immunome Inc (IMNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,393,438
  • Shares Outstanding, K 54,752
  • Annual Sales, $ 0 K
  • Annual Income, $ -36,900 K
  • 60-Month Beta 1.67
  • Price/Sales 30.41
  • Price/Cash Flow N/A
  • Price/Book 48.60
Trade IMNM with:

Options Overview Details

View History
  • Implied Volatility 111.54% ( +4.28%)
  • Historical Volatility 131.87%
  • IV Percentile 83%
  • IV Rank 39.42%
  • IV High 198.67% on 08/28/23
  • IV Low 54.86% on 12/21/23
  • Put/Call Vol Ratio 0.03
  • Today's Volume 183
  • Volume Avg (30-Day) 548
  • Put/Call OI Ratio 0.16
  • Today's Open Interest 4,279
  • Open Int (30-Day) 2,890

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.28
  • Number of Estimates 3
  • High Estimate -0.23
  • Low Estimate -0.37
  • Prior Year -0.64
  • Growth Rate Est. (year over year) +56.25%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.10 +53.66%
on 02/05/24
27.82 -11.07%
on 02/28/24
+8.45 (+51.87%)
since 02/02/24
3-Month
6.93 +257.00%
on 12/14/23
27.82 -11.07%
on 02/28/24
+16.76 (+210.03%)
since 12/04/23
52-Week
4.18 +491.87%
on 03/08/23
27.82 -11.07%
on 02/28/24
+20.24 (+449.78%)
since 03/03/23

Most Recent Stories

More News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AEL, KLR, IMNM

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

AEL : 55.58 (-0.07%)
KLR : 7.24 (-0.14%)
IMNM : 24.84 (-2.40%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IMNM, CPRI, AVID

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

IMNM : 24.84 (-2.40%)
CPRI : 45.81 (+0.12%)
AVID : 27.04 (unch)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates WMC, SGTX, AJX, IMNM

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

WMC : 9.18 (+4.44%)
SGTX : 22.47 (-2.56%)
AJX : 4.06 (+0.23%)
IMNM : 24.84 (-2.40%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates KDNY, WMC, IMNM, AJX

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

KDNY : 40.39 (+0.22%)
WMC : 9.18 (+4.44%)
IMNM : 24.84 (-2.40%)
AJX : 4.06 (+0.23%)
IMPORTANT ALERT: Halper Sadeh LLC Investigates DICE, IMNM, AJX

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

DICE : 47.55 (+0.06%)
IMNM : 24.84 (-2.40%)
AJX : 4.06 (+0.23%)
Shareholder Alert: Ademi LLP investigates whether Immunome, Inc. has obtained a Fair Price in its Private Placement and its transaction with Morphimmune

/PRNewswire/ -- Ademi LLP is investigating Immunome (Nasdaq: IMNM) for possible breaches of fiduciary duty and other violations of law in its private placement...

IMNM : 24.84 (-2.40%)
Immunome (NASDAQ: IMNM) and Morphimmune Announce Merger to Develop Best-in-Class Targeted Cancer Therapies

Immunome (Nasdaq: IMNM), a biopharmaceutical company specializing in antibody therapeutics, and Morphimmune, a biotech firm known for targeted oncology therapeutics, have entered into a definitive merger...

PFE : 26.02 (-2.14%)
IMNM : 24.84 (-2.40%)
Here's What Could Help Immunome, Inc. (IMNM) Maintain Its Recent Price Strength

Immunome, Inc. (IMNM) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through...

IMNM : 24.84 (-2.40%)
Immunome Reports First Quarter 2023 Financial Results

Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company that utilizes its human memory B cell platform to discover and develop first-in-class antibody therapeutics to improve patient care, today reported...

IMNM : 24.84 (-2.40%)
Immunome, Inc. (IMNM) is on the Move, Here's Why the Trend Could be Sustainable

If you are looking for stocks that are well positioned to maintain their recent uptrend, Immunome, Inc. (IMNM) could be a great choice. It is one of the several stocks that passed through our "Recent Price...

IMNM : 24.84 (-2.40%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Immunome, Inc. is a biopharmaceutical company utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. Immunome, Inc. is based in Exton, United States.

See More

Key Turning Points

3rd Resistance Point 28.35
2nd Resistance Point 27.32
1st Resistance Point 26.38
Last Price 24.84
1st Support Level 24.41
2nd Support Level 23.38
3rd Support Level 22.44

See More

52-Week High 27.82
Last Price 24.84
Fibonacci 61.8% 18.79
Fibonacci 50% 16.00
Fibonacci 38.2% 13.21
52-Week Low 4.18

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar